Global Cord Blood
CORBF
$0.71
Share price
29.09%
Change (1 day)
-52.67%
Change (1 year)
Categories
P/S ratio for Global Cord Blood (CORBF)
P/S ratio as of July 2025 (TTM): 1.34
According to Global Cord Blood's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.3365. At the end of 2022 the company had a P/S ratio of 2.41.
P/S ratio history for Global Cord Blood from 2010 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 2.41 | -8.46% |
| 2021 | 2.63 | -1.45% |
| 2020 | 2.67 | -25.66% |
| 2019 | 3.59 | -33.38% |
| 2018 | 5.39 | -35.36% |
| 2017 | 8.35 | 100.03% |
| 2016 | 4.17 | -4.7% |
| 2015 | 4.38 | 33.98% |
| 2014 | 3.27 | 0.99% |
| 2013 | 3.24 | 33.14% |
| 2012 | 2.43 | -27.1% |
| 2011 | 3.33 | -48.27% |
| 2010 | 6.45 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Cryo-Cell CCEL | 1.23 | -7.55% | 🇺🇸 USA |
 NeoGenomics
NEO | 1.24 | -7.42% | 🇺🇸 USA |
 RadNet RDNT | 2.38 | 78.09% | 🇺🇸 USA |
 National Healthcare
NHC | 1.08 | -19.25% | 🇺🇸 USA |